HSBC Holdings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-900
| Closed | -$423K | – | 3099 |
|
|
2023
Q4 | $423K | Sell |
900
-800
| -47% | -$370K | ﹤0.01% | 2116 |
|
|
2023
Q3 | $749K | Sell |
1,700
-600
| -26% | -$272K | ﹤0.01% | 1819 |
|
|
2023
Q2 | $1.02M | Hold |
2,300
| – | – | ﹤0.01% | 1705 |
|
|
2023
Q1 | $1.06M | Sell |
2,300
-11,300
| -83% | -$5.38M | ﹤0.01% | 1739 |
|
|
2022
Q4 | $6.93M | Hold |
13,600
| – | – | 0.01% | 1116 |
|
|
2022
Q3 | $6.27M | Hold |
13,600
| – | – | 0.01% | 1087 |
|
|
2022
Q2 | $6.57M | Buy |
13,600
+9,500
| +232% | +$4.7M | 0.01% | 1084 |
|
|
2022
Q1 | $2.07M | Sell |
4,100
-14,500
| -78% | -$6.63M | ﹤0.01% | 1587 |
|
|
2021
Q4 | $8.7M | Buy |
18,600
+2,200
| +13% | +$926K | 0.01% | 1030 |
|
|
2021
Q3 | $6.16M | Hold |
16,400
| – | – | 0.01% | 1074 |
|
|
2021
Q2 | $6.24M | Buy |
+16,400
| New | +$6.27M | 0.01% | 1025 |
|
|
2021
Q1 | – | Sell |
-4,300
| Closed | -$1.37M | – | 2830 |
|
|
2020
Q4 | $1.37M | Buy |
+4,300
| New | +$1.32M | ﹤0.01% | 1505 |
|
|
2020
Q1 | – | Sell |
-15,500
| Closed | -$4.66M | – | 2777 |
|
|
2019
Q4 | $4.66M | Hold |
15,500
| – | – | 0.01% | 1134 |
|
|
2019
Q3 | $3.72M | Sell |
15,500
-5,000
| -24% | -$1.37M | 0.01% | 1310 |
|
|
2019
Q2 | $5.79M | Sell |
20,500
-2,200
| -10% | -$601K | 0.01% | 1085 |
|
|
2019
Q1 | $6.51M | Buy |
22,700
+9,500
| +72% | +$2.75M | 0.01% | 1010 |
|
|
2018
Q4 | $3.47M | Hold |
13,200
| – | – | 0.01% | 1264 |
|
|
2018
Q3 | $3.62M | Hold |
13,200
| – | – | 0.01% | 1256 |
|
|
2018
Q2 | $3.14M | Buy |
13,200
+9,000
| +214% | +$2.08M | 0.01% | 1330 |
|
|
2018
Q1 | $923K | Buy |
+4,200
| New | +$987K | ﹤0.01% | 1671 |
|
|
2017
Q4 | – | Sell |
-900
| Closed | -$171K | – | 2144 |
|
|
2017
Q3 | $171K | Hold |
900
| – | – | ﹤0.01% | 2194 |
|
|
2017
Q2 | $169K | Sell |
900
-12,800
| -93% | -$2.3M | ﹤0.01% | 2089 |
|
|
2017
Q1 | $2.27M | Hold |
13,700
| – | – | ﹤0.01% | 1189 |
|
|
2016
Q4 | $1.97M | Buy |
+13,700
| New | +$1.83M | ﹤0.01% | 1210 |
|
|
2016
Q1 | – | Sell |
-10,000
| Closed | -$1.39M | – | 2126 |
|
|
2015
Q4 | $1.39M | Buy |
+10,000
| New | +$1.38M | ﹤0.01% | 1366 |
|
|
2014
Q1 | – | Sell |
-25,000
| Closed | -$2.31M | – | 1748 |
|
|
2013
Q4 | $2.31M | Buy |
+25,000
| New | +$2.22M | 0.01% | 1084 |
|
Other funds holding ELV
VCM
VPM
HSBC Holdings's ELV Position: Q1 2026 in Review
HSBC Holdings increased its Elevance Health (ELV) stake by 0.9% in Q1 2026, buying an estimated $1.5M and bringing the position to 511,067 shares worth $150M. The position accounts for 0.08% of the portfolio, ranked #244.
HSBC Holdings first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- HSBC Holdings held 511,067 shares of Elevance Health worth $150M as of Q1 2026.
- HSBC Holdings bought 4,563 Elevance Health shares in Q1 2026, an estimated $1.5M.
- Elevance Health made up 0.08% of HSBC Holdings's portfolio in Q1 2026, its #244 holding.
- HSBC Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Elevance Health position peaked at $480M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.